日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent

丙型肝炎病毒E1E2糖蛋白关键中和位点的抗原性与基因型无关

Mimms, Jessica L; Sinnis-Bourozikas, Ariadne; Felbinger, Nathaniel R; Frumento, Nicole; Paul, Harry T; Patel, Arvind H; Keck, Zhenyong; Foung, Steven K H; Law, Mansun; Urbanowicz, Richard A; Tarr, Alexander W; Ball, Jonathan K; Pierce, Brian G; Bailey, Justin R

Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers.

利用二价 Fab 作为参考标记,确定了 HCV E2 糖蛋白与中和抗体和非中和抗体结合的冷冻电镜结构

Shahid Salman, Karade Sharanbasappa S, Hasan S Saif, Yin Rui, Jiang Liqun, Liu Yanxin, Felbinger Nathaniel, Kulakova Liudmila, Toth Eric A, Keck Zhen-Yong, Foung Steven K H, Fuerst Thomas R, Pierce Brian G, Mariuzza Roy A

Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone

重组H77C gpE1/gpE2异二聚体比单独的H77C gpE2具有更强的HCV交叉中和能力。

Kundu, Juthika; Le, Hoa T; Logan, Michael; Hockman, Darren; Landi, Abdolamir; Crawford, Kevin; Wininger, Mark; Johnson, Janelle; Kundu, Joydeb K; Tiffney, E Alana; Urbanowicz, Richard A; Ball, Jonathan K; Bailey, Justin R; Bukh, Jens; Law, Mansun; Foung, Steven; Tyrrell, D Lorne; Houghton, Michael; Law, John Lokman

An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development

用于丙型肝炎病毒疫苗研发的具有抗原多样性和代表性的包膜糖蛋白样本库

Salas, Jordan H; Urbanowicz, Richard A; Guest, Johnathan D; Frumento, Nicole; Figueroa, Alexis; Clark, Kaitlyn E; Keck, Zhenyong; Cowton, Vanessa M; Cole, Sarah J; Patel, Arvind H; Fuerst, Thomas R; Drummer, Heidi E; Major, Marian; Tarr, Alexander W; Ball, Jonathan K; Law, Mansun; Pierce, Brian G; Foung, Steven K H; Bailey, Justin R

Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate

利用丙型肝炎病毒E1E2异二聚体的分泌形式作为候选疫苗诱导广谱中和抗体

Wang, Ruixue; Suzuki, Saori; Guest, Johnathan D; Heller, Brigitte; Almeda, Maricar; Andrianov, Alexander K; Marin, Alexander; Mariuzza, Roy A; Keck, Zhen-Yong; Foung, Steven K H; Yunus, Abdul S; Pierce, Brian G; Toth, Eric A; Ploss, Alexander; Fuerst, Thomas R

Insulin oedema in type 2 diabetes mellitus: A case report

2型糖尿病胰岛素性水肿:病例报告

Md Aris, Mohd Aznan; Tan, Kui Foung; Said, Abdul Hadi

Structural perspectives on HCV humoral immune evasion mechanisms

丙型肝炎病毒体液免疫逃逸机制的结构视角

Sevvana, Madhumati; Keck, Zhenyong; Foung, Steven Kh; Kuhn, Richard J

The impact of the rare disease and Orphan Drug Act in Taiwan

台湾罕见病及孤儿药法的影响

Hsiang, Ning-Chun; Huang, Weng-Foung; Gau, Churn-Shiouh; Tsai, Teng-Wen; Chang, Lin-Chau

Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer

丙型肝炎病毒 E1E2 异二聚体的天然样分泌形式的设计

Johnathan D Guest, Ruixue Wang, Khadija H Elkholy, Andrezza Chagas, Kinlin L Chao, Thomas E Cleveland 4th, Young Chang Kim, Zhen-Yong Keck, Alexander Marin, Abdul S Yunus, Roy A Mariuzza, Alexander K Andrianov, Eric A Toth, Steven K H Foung, Brian G Pierce, Thomas R Fuerst

SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution

健康献血者在呼吸道疾病痊愈后 40 天出现 SARS-CoV-2 RNA 血症

Pham, Tho D; Huang, ChunHong; Wirz, Oliver F; Röltgen, Katharina; Sahoo, Malaya K; Layon, Arlene; Pandey, Suchitra; Foung, Steven K; Boyd, Scott D; Pinsky, Benjamin A